OSUCCC – James CEO W. Kimryn Rathmell, MD, PhD, shares some thoughts on the unparallelled partnership between The James and Pelotonia during tonight’s Opening Ceremony.
Thank you @KimrynRathmell for your support of the @Pelotonia Roundtable and our innovative @OSUCCC_James researchers and providers who are engaging industry with their creative ideas designed to #endcancer
The Roundtable was a great opportunity to showcase how @OSUCCC_James is pushing the boundaries of science to ensure people have access to clinical studies no matter where they live.
Big thank you to @eric_olsavsky and @becca2070 for making the Roundtable such a success!
🎉 We're excited to welcome three new faculty members to the Division of Hematology starting today! Drs. @RobertaAzbellMD, Amneet Bajwa, and @Revisionary (John Patton) bring expertise, passion, and strong Buckeye roots to our expanding clinical and research programs.
We had a great time celebrating all of the wonderful women in oncology in honor of International Day of Women and Girls in Science. Thanks to all who attended, including @KimmelCancerCtr's Elizabeth Jaffee, MD, who was honored with the 2025 Clara D. Bloomfield, MD, Legacy Award.
🚀 Today is International Day of Women & Girls in Science! 🧬🥼 Celebrate with us by hearing from incredible women faculty @OSUCCC_James as they share why they chose a career in science. 🔬✨ #WomenInScience#IDWGS@OhioStateWIMS
What does cutting #NIHindirects mean? Science is like trying to make a cake. Direct costs cover ingredients & bakers’ time, but indirects cover everything else: oven, bowls, electricity, the building, dishwasher etc. You can’t make a cake without covering both. #SupportResearch
Great #indirectcosts graphic explaining why @NIH cut to 15% F&A rate is unsustainable for institutions that need NIH partnership to ensure #biomedicalresearch is conducted responsibly and safely. Loss to the US economy will be devastating!
Please share! We are trying to reach patients with painful diabetic neuropathy for enrollment in our NIH-funded clinical trial that is now underway, testing neuromodulation and our diagnostic device. Patients are compensated. With @NeurosurgeryOSU Brian Dalm.
🩺On National Women Physicians Day, we recognize the excellent care our @OSUCCC_James#medicaloncology women physicians provide to their patients, their important contributions to science, and their mentoring and leadership!
Congratulations to @OSUCCC_James Executive Director David Gosky being recognized with the @CancerExecs 2025 Marsha Fountain Award for Excellence in Oncology Administration.
Truly deserved award for a great advocate for improving cancer care.
Kudos to @sizemorelabs1 for leading the planning committee and to @StoverLab for organizing informative sessions for the #2024GLBCRS hosted @OSUCCC_James that included excellent Keynotes by Drs. @AlanaWelm and Susan Domchek. The panel of breast cancer advocates was a highlight!